Pages that link to "Template:DocumentData"

The following pages link to Template:DocumentData:

Displaying 50 items.

• Reference:FRA Constitution du 4 octobre 1958 10-Mar-2024 Article 24 (transclusion) (← links)
• Reference:FRA Constitution du 4 octobre 1958 10-Mar-2024 Article 34 (transclusion) (← links)
• Reference:FRA Constitution du 4 octobre 1958 10-Mar-2024 Article 37 (transclusion) (← links)
• Reference:FRA Constitution du 4 octobre 1958 10-Mar-2024 Article 38 (transclusion) (← links)
• Reference:FRA Guide de légistique 07-Feb-2024 - (transclusion) (← links)
• Reference:FRA Infographie - La hiérarchie des normes 22-Mar-2024 - (transclusion) (← links)
• Reference:ICH ICH E6 Guideline R3 (2025) GLOSSARY - Regulatory Authorities (transclusion) (← links)
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 11 (transclusion) (← links)
• Reference:DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 77 (transclusion) (← links)
• Reference:DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 85 (transclusion) (← links)
• Reference:DEU TAMG - Tierarzneimittelgesetz 14-Mar-2024 § 65 (transclusion) (← links)
• Reference:FRA Code de la Santé Publique - Partie législative - 1ere partie, Livre 1er, Titre II 16-May-2025 L5311-1 (transclusion) (← links)
• Reference:USA 21 CFR Part 54 09-Apr-2025 § 54.1-001 (transclusion) (← links)
• Reference:ICH ICH E6 Guideline R3 (2025) GLOSSARY - Institutional Review Board (IRB)/Independent Ethics Committee (IEC) (transclusion) (← links)
• Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 1 (transclusion) (← links)
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - ethics committee (transclusion) (← links)
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 3.2 - Introduction (transclusion) (← links)
• Reference:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 3.24 (transclusion) (← links)
• Reference:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 3.26 (transclusion) (← links)
• Reference:WMA Declaration of Helsinki 2024 Paragraph 23 (transclusion) (← links)
• Reference:CIOMS CIOMS - International Ethical Guidelines for Biomedical Research Involving Human Subjects 2016 Page 20 (transclusion) (← links)
• Reference:DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 41a (transclusion) (← links)
• Reference:DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 41b (transclusion) (← links)
• Reference:DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 41c (transclusion) (← links)
• Reference:DEU KPBV - Klinische Prüfung-Bewertungsverfahren-Verordnung 31-Jan-2022 § 4 (transclusion) (← links)
• Reference:DEU KPBV - Klinische Prüfung-Bewertungsverfahren-Verordnung 31-Jan-2022 § 5 (transclusion) (← links)
• Reference:DEU DGEPi - GEP Guter Epidemiologischer Praxis Sep-2018 Leitlinie 1 1.1 ; 1.3 (transclusion) (← links)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 2 relevant ethics committee (transclusion) (← links)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 5-6 (transclusion) (← links)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 7-10 (transclusion) (← links)
• Reference:USA 21 CFR Part 50 09-Apr-2025 § 50.3 (i) (transclusion) (← links)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.3 - IEC (transclusion) (← links)
• Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.3 (f) (transclusion) (← links)
• Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.3 (t) (transclusion) (← links)
• Reference:USA 21 CFR Part 56 09-Apr-2025 - (transclusion) (← links)
• Reference:USA 21 CFR Part 56 09-Apr-2025 Subpart B (transclusion) (← links)
• Reference:USA 21 CFR Part 56 09-Apr-2025 Subpart C (transclusion) (← links)
• Reference:USA 45 CFR Part 46 09-Apr-2025 § 46.107 - § 46.112 (transclusion) (← links)
• Reference:USA 45 CFR Part 46 09-Apr-2025 § 46.115 (transclusion) (← links)
• Reference:USA 45 CFR Part 46 09-Apr-2025 Subpart E (transclusion) (← links)
• Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 3.8 (transclusion) (← links)
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 3.2 - Consultation (transclusion) (← links)
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 4.8 - 4.9 (transclusion) (← links)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 4 (transclusion) (← links)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 5 (transclusion) (← links)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 6 (transclusion) (← links)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 7 (transclusion) (← links)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 8 (transclusion) (← links)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 9 (transclusion) (← links)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 10 (transclusion) (← links)